Tibet Cheezheng Tibetan Medicine Co Ltd (002287) — Cash Flow Quality Index
Tibet Cheezheng Tibetan Medicine Co Ltd (002287) has a Cash Flow Quality Index of 0.53x as of September 2025. Operating cash flow of CN¥34.69 Million is below net income of CN¥65.12 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Tibet Cheezheng Tibetan Medicine Co Ltd long-term investment allocation to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Tibet Cheezheng Tibetan Medicine Co Ltd Cash Flow Quality Index (2006–2025)
Historical Cash Flow Quality Index for Tibet Cheezheng Tibetan Medicine Co Ltd across 20 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 002287 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Tibet Cheezheng Tibetan Medicine Co Ltd (2006–2025)
Year-by-year earnings quality comparison for Tibet Cheezheng Tibetan Medicine Co Ltd. For live market cap and the full company financial profile, see 002287 company net worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.13x | CN¥729.70 Million | CN¥648.43 Million | ▲ +43.2% |
| 2024 | 0.79x | CN¥456.75 Million | CN¥581.37 Million | ▼ -34.4% |
| 2023 | 1.20x | CN¥693.41 Million | CN¥579.18 Million | ▲ +96.8% |
| 2022 | 0.61x | CN¥285.69 Million | CN¥469.51 Million | ▼ -58.2% |
| 2021 | 1.46x | CN¥1.03 Billion | CN¥710.83 Million | ▲ +147.6% |
| 2020 | 0.59x | CN¥238.65 Million | CN¥405.92 Million | ▼ -47.2% |
| 2019 | 1.11x | CN¥405.95 Million | CN¥364.39 Million | ▼ -29.2% |
| 2018 | 1.57x | CN¥499.40 Million | CN¥317.44 Million | ▲ +105.9% |
| 2017 | 0.76x | CN¥229.83 Million | CN¥300.77 Million | ▼ -43.5% |
| 2016 | 1.35x | CN¥389.20 Million | CN¥287.79 Million | ▲ +37.1% |
| 2015 | 0.99x | CN¥257.81 Million | CN¥261.36 Million | ▼ -25.3% |
| 2014 | 1.32x | CN¥310.95 Million | CN¥235.47 Million | ▲ +40.5% |
| 2013 | 0.94x | CN¥198.48 Million | CN¥211.17 Million | ▲ +4.0% |
| 2012 | 0.90x | CN¥169.67 Million | CN¥187.80 Million | ▲ +1413.6% |
| 2011 | -0.07x | CN¥-11.74 Million | CN¥170.65 Million | ▼ -112.1% |
| 2010 | 0.57x | CN¥96.91 Million | CN¥170.59 Million | ▼ -47.9% |
| 2009 | 1.09x | CN¥175.58 Million | CN¥161.18 Million | ▲ +124.6% |
| 2008 | 0.48x | CN¥65.93 Million | CN¥135.95 Million | ▼ -38.5% |
| 2007 | 0.79x | CN¥91.43 Million | CN¥115.93 Million | ▲ +113.8% |
| 2006 | 0.37x | CN¥38.50 Million | CN¥104.35 Million | — |